ProCE Banner Activity

Expert Insights on Targeting Residual Inflammatory Risk in ASCVD and CKD

Slideset

Accompanying slides for a text module on the pivotal role nephrology healthcare professionals have in caring for patients with ASCVD and CKD, including addressing systemic or residual inflammation with novel therapies.

Released: July 22, 2024

Expiration: July 21, 2025

Share

Faculty

Erin Michos

Erin Michos, MD, MHS, FACC, FAHA, FASE, FASPC

Professor of Medicine
Director of Women’s Cardiovascular Health Research
Associate Director of Preventive Cardiology
Division of Cardiology
Johns Hopkins University School of Medicine
Co Center-Director, IMPACT Center at JHU
(Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials)
Co-Editor in Chief
American Journal of Preventive Cardiology
Baltimore, Maryland

Provided by

Provided by Clinical Care Options, LLC in collaboration with American Kidney Fund

ProCE Banner

Supporters

Supported by an educational grant from Novo Nordisk.

Novo Nordisk

Partners

American Kidney Fund

ProCE Banner